Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.
Status:
Completed
Trial end date:
2001-11-01
Target enrollment:
Participant gender:
Summary
This pilot study was designed to evaluate the effectiveness and tolerability of the
buprenorphine transdermal system versus placebo on health outcomes in elderly residents in
supervised living environments. The treatment intervention duration is 42 days during which
time supplemental analgesic medication (usual analgesic care) will be provided to all
subjects in addition to study drug.